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measure intestinal calcium absorption
compared to gold-standard methods?
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Abstract
Background: Low fractional calcium absorption (FCA) contributes to osteoporosis but is not measured clinically, as
the gold-standard method requires administration of two calcium tracers and a subsequent 24-h urine collection.
We evaluated alternate methods to measure FCA, compared to the gold standard method.
Methods: We administered two stable calcium isotope tracers (~8 mg oral 44Ca and ~3 mg intravenous 42Ca) with
breakfast to 20 fasting post-menopausal women (Cohort 1) 59 ± 7 years old with vitamin D insufficiency. We
measured subsequent calcium isotope concentrations in 24-h urine samples and serum collected 1, 3 and 5 h post
tracer administration during an inpatient research stay. We assessed the candidate serum estimates in a second
cohort of 9 women with similar characteristics. Methods of measuring FCA were compared using correlation
coefficients and Bland-Altman tests.
Results: FCA estimated from a 3-h serum sample correlated highest with the levels from the 24-h urine collection
(ρ 0.78, p < 0.001), but explained only 58 % of the variance in FCA. The total variance explained by 3-h estimates
improved to 61 % with incorporation of glomerular filtration rate (GFR). FCA estimates from the 3-h serum
measurement were assessed in a second group of nine women (Cohort 2) 60 ± 7 years old. In this cohort, however,
FCA estimated by 3-h serum isotope levels did not correlate with gold-standard FCA measurements, whether
determined with (ρ 0.02, p = 0.97) or without GFR values (ρ 0.03, p = 0.93). By contrast, FCA in Cohort 2 correlated
best with 5-h serum isotope levels (ρ 0.75, p = 0.02).
Conclusions: We conclude that serum isotope levels correlate with true fractional calcium absorption, but do not
reliably estimate FCA when analyzed using Bland-Altman tests, compared to gold-standard methods.
Trial registration: ClinicalTrials.gov.Identifier: NCT00933244
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Background
Nearly half of postmenopausal women sustain an osteo-
porotic fracture [1] and low calcium absorption is a risk
factor for hip fracture [2]. Postmenopausal women have
surprisingly high variability in calcium absorption efficiency,
ranging from <10 to >50 % [3, 4]. Calcium absorption is in-
fluenced by numerous factors including age, calcium intake,
estrogen status, vitamin D stores, gastrointestinal disorders
and genetic factors [5, 6]. Measurement of calcium absorp-
tion could be performed, to recommend interventions to
increase absorption and reduce fracture risk. Unfortunately,
clinicians do not routinely measure calcium absorption in
patients with osteoporosis due to lack of an accurate, inex-
pensive and time-efficient method.
Administration of an oral and an intravenous calcium
tracer, followed by analysis of the dose-corrected ratio of
the two tracers in a subsequent 24-h urine collection, is
the gold-standard method to measure true fractional cal-
cium absorption (FCA) [7]. The intravenous tracer allows
a more precise measurement of FCA that accounts for
renal calcium recycling and intestinal calcium secretion.
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Although validated [7], the method is time consuming
and costly. Therefore, many researchers administer a sin-
gle oral calcium tracer and measure its serum level 1-6 h
later, to estimate FCA [3, 8–11]. While more efficient, the
single isotope method might be less accurate than the 24-
h urine method. Peak plasma tracer levels can be influ-
enced by intestinal calcium excretion and transit time,
renal calcium recycling and volume of calcium distribu-
tion. In 1994, Yergey et al. [12] assessed spot serum iso-
tope levels at multiple time points within 24 h of tracer
administration and concluded, by Bland-Altman analysis,
that spot serum levels were inaccurate and introduced up
to 69 % error in estimates of FCA.
Nonetheless, several researchers reported that single iso-
tope methods correlate well with FCA. However, most
studies did not use the 24-h urine method as the gold-
standard method by which to assess serum estimates of
FCA. Additionally, correlation coefficients were used to
analyze data, rather than the Bland-Altman test [13], which
more rigorously assesses agreement between two methods
of measurement. Moreover, only one study [8] employed
two cohorts, one to test candidate methods and a second
to validate the best candidate method. Finally, few studies
evaluated serum methods in postmenopausal women, a
population at greatest risk for osteoporosis and in whom
measurement would be most relevant clinically.
We evaluated whether serum isotope levels collected 1, 3
and 5 h post-tracer administration could accurately meas-
ure FCA in the first 29 postmenopausal women random-
ized into an ongoing clinical trial. We also examined
whether incorporation of other factors, such as demo-
graphic, physical, dietary or laboratory attributes, could im-
prove the accuracy of serum tracer estimates of FCA. We
evaluated methods in an initial cohort, and then assessed
predictor equations in a second cohort of subjects.
Methods
Subjects
We recruited participants for the study, “Treatment of
Vitamin D Insufficiency,” (clinicaltrials.gov NCT00933244)
through newspaper advertisements and letters of invitation
to University of Wisconsin (UW) employees and partici-
pants of a research registry. Eligible subjects had serum
25(OH)D levels between 35 and 67 nmol/L (14 and 27 ng/
mL) and were ≥5 years post-menopausal, or ≥60 years old
if they reported hysterectomy without bilateral oophorec-
tomy. Women were excluded if ≥75 years old or if they re-
ported hypercalcemia, nephrolithiasis, inflammatory bowel
disease, malabsorption, chronic diarrhea, diabetes, osteo-
porosis or had a GFR <45 mL/min based on the MDRD
equation [14]. Subjects were also excluded if they had used
bisphosphonates, estrogen compounds, calcitonin, teripara-
tide, oral corticosteroids or anticonvulsants within the prior
six months.
Procedures
Potentially eligible subjects, based on phone interviews,
attended a screening visit at the UW Clinical Research Unit
(CRU). Subjects completed a food frequency questionnaire
[15] to estimate total (dietary and supplemental) calcium
intake; subjects who agreed to consume 600-1400 mg of
calcium/day were eligible for the study. Phlebotomy was
performed to measure subjects’ serum 25(OH)D concentra-
tion via HPLC [16], serum calcium using cresolpthalein,
albumin using bromocresol, creatinine using an IDMS-
traceable methods and PTH using a chemilluminescent
assay. Subjects who were eligible after the first visit under-
went measurement of spine, hip and total body bone min-
eral density (GE Healthcare, Madison, WI); those with
osteoporosis were excluded. The consent process included
two verbal descriptions of the study (during the phone
screen and first screening visit) followed by a written con-
sent form which subjects were required to read and sign,
prior to any study procedures. The study was approved by
the UW Human Subjects Committee.
Eligible subjects completed a consecutive four-day food
diary encompassing one weekend. The study nutritionist
analyzed diet diaries using Food Processor software (ESHA
Research, Salem OR, USA) to determine typical daily in-
take of energy, macronutrients, fiber, calcium, iron, magne-
sium, sodium, vitamin D, oxalate, caffeine and alcohol. The
nutritionist designed each subject’s 24-h inpatient diet to
replicate her typical outpatient consumption of nutrients.
To measure FCA using the gold-standard approach [7],
subjects were admitted to the CRU at 0700 after fasting
since midnight. Upon arrival, the subjects consumed break-
fast containing a 300 mg calcium load, simultaneously
drinking ≤50 mL of calcium-fortified orange juice contain-
ing ~8 mg of 44Ca and receiving ~3 mg of 42Ca intraven-
ously over 5 min. The calcium isotope syringes were
weighed before and after use to record the administered
doses of 42Ca and 44Ca. Research nurses collected subjects’
urine for 24 h and blood samples 1, 3 and 5 h after isotope
dosing. We chose to test these times because other re-
searchers [2, 3, 11, 17] frequently estimated FCA using
serum isotope levels at these time points. We calculated
24-h FCA using the Eastell formula [7]:
FCA ¼ Δ% excess 44 Ca oralð Þ
Δ% excess 42
Ca intravenousð Þ






Stable calcium isotopes (44Ca and 42Ca) were pur-
chased from Trace Sciences (Wilmington, Deleware) as
calcium carbonate powder; purity and enrichment were
confirmed by high-resolution inductively coupled plasma
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mass spectrometry (HR-ICP-MS, ThermoFinnigan Elem-
ent 2). The Waisman Clinical Biomanufacturing Facility
reconstituted the calcium powders as previously described
[18] and tested solutions for sterility and pyrogenicity.
Personnel at the Wisconsin State Lab of Hygiene measured
calcium isotope ratios using 43Ca as the internal standard
(42Ca/43Ca and 44Ca/43Ca) in subjects’ serum and 24-h
urine specimens by HR-ICP-MS, as previously described
[18]. Briefly, each measured isotope ratio represented the
average of five separate runs, each run consisting of 900
scans of the mass range of index. Precision of measure-
ments were excellent, with an intra-assay and inter-assay
coefficient of variation of 0.4 and 0.7 %, respectively.
Statistical analysis
Data exhibited a normal distribution by normal probability
plot and were summarized using the mean and standard
deviation (SD). We used Spearman correlation coefficients
(ρ), Bland-Altman tests and root mean square prediction
errors to compare FCA determined from individual
serum measurements to gold-standard measurements.
For Bland-Altman analysis [13], a p-value >0.05 indi-
cated no significant difference between paired values
obtained using gold-standard and serum methods to
measure FCA. Thus, a Bland-Altman p-value >0.05
would indicate that the two methods of FCA measure-
ment are in agreement. We employed linear regression
models to predict FCA based on subjects’ serum isotope
levels, demographic, dietary and laboratory variables. Lin-
ear regression models were subsequently validated in Co-
hort 2. Statistical analyses were performed using R
software (Version 3.0.1, The R Project for Statistical
Computing, http://www.r-project.org) and Analyze-It (Ver-
sion 3.15, Leeds UK). In all analyses, a p-value <0.05 was
considered significant.
Results
The characteristics of Cohort 1 and Cohort 2 are summa-
rized in Table 1. Based on outpatient food diaries, Cohort 1
consumed 856 ± 352 (mean ± SD) mg calcium per day and
FCA (based on a 24-h urine collection) was 0.20 ± 0.06.
FCA, based on the 24-h urine collection, correlated most
closely with 3-h serum levels (ρ 0.72, p < 0.001) as
compared to the 1-h (ρ 0.57, p = 0.008) and 5-h (ρ 0.65,
p = 0.002) serum samples (Table 2; Figs. 1, 2, 3). There
was no significant Bland-Altman bias between 24-h
FCA and FCA estimated from 3- and 5-h serum levels.
However, 1-h serum levels significantly overestimated
24-h urine FCA (bias +0.055, p < 0.001). In contrast to
other reports [3, 8, 9], we found no improvement in
correlation or variance, when serum levels were cor-
rected for body surface area.
We derived linear regression equations using serum
tracer levels to predict 24-h urine FCA measurements.
FCA determined from 3-h serum levels (FCA =Value x
0.577 + 0.081) explained the greatest variance in 24-h urine
FCA levels (R2 0.58, p < 0.001). By contrast, linear regres-
sion equations using 1-h and 5-h serum levels explained
only 29 and 36 % of the variance in 24-h urine FCA, re-
spectively. In multivariate analyses, incorporation of sub-
jects’ GFR with their 3-h serum tracer measurement
improved R2 to 0.61 (p < 0.001). Surprisingly, incorporation
of subjects’ body surface area, body mass index, age, cal-
cium intake, PTH and 25(OH)D levels did not improve
ability to predict true FCA values.
Table 1 Characteristics of subjects undergoing measurement of calcium absorption
Cohort 1a Cohort 2b p-value
n = 20 n = 9
Age, yearsc 59 ± 7 60 ± 7 0.58
Race 18 White, 2 Black 5 White, 2 Black, 1 Hispanic, 1 Native American
BMI, kg/m2 29 ± 5 36 ± 2 0.01
Calcium intake, mg/day 856 ± 352 1016 ± 453 0.31
Fractional Calcium Absorption 0.20 ± 0.06 0.23 ± 0.07 0.18
Serum Calcium, mmol/L 2.29 ± 0.09 2.26 ± 0.09 0.47
Serum Albumin, g/L 39 ± 2 36 ± 2 <0.001
Serum Magnesium, mmol/L 1.10 ± 0.13 1.08 ± 0.06 0.75
Serum Phosphorus, mmol/L 1.16 ± 0.15 1.00 ± 0.20 0.02
Serum 25(OH)D, nmol/L 54 ± 6 55 ± 11 0.70
Serum Parathyroid Hormone, ng/L 48 ± 19 43 ± 16 0.56
Serum Creatinine, μmol/L 77 ± 18 83 ± 13 0.44
aCohort 1 was used to evaluate spot serum isotope approaches to measuring calcium absorption, using the dose-corrected levels of two stable calcium isotopes
in a 24-h urine collection as the referent method
bCohort 2 data was used to validate equations derived from Cohort 1
cAll data exhibited a normal distribution and are expressed as mean ± standard deviation
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We used Cohort 2 values to validate findings identi-
fied in Cohort 1. The characteristics of women in Co-
hort 2 were similar to those of Cohort 1 (Table 1)
except for higher BMI (p = 0.01) and lower serum al-
bumin (p < 0.001) and phosphorus (p = 0.02) levels.
Cohorts 1 and 2 had similar FCA (Table 1). In Cohort
2, 24-h urine FCA correlated with 5-h serum estimates
(ρ 0.75, p = 0.02) but not with 1-h estimates (ρ 0.40, p =
0.29) or 3-h estimates (ρ 0.03, p = 0.92) (Figs. 1, 2, 3).
However, 5-h serum estimates explained only 35 % of the
variance in 24-h urine FCA values.
Table 3 summarizes how well the best method identified
in Cohort 1 (a linear regression equation using 3-h serum
isotope values) predicted 24-h urine FCA values in Cohort
2. We found that 24-h FCA did not correlate with 3-h
serum estimates entered into a linear regression equation,
either with GFR (ρ 0.02, p = 0.97) or without GFR (ρ 0.03,
p = 0.93). However, one outlier in Cohort 2 had a low 24-h
urine FCA of 0.12. When we removed this subject’s data
from analyses, we still found no significant correlation
between the 24-h urine and 3-h serum FCA levels with
GFR (ρ 0.45, p = 0.26) or without GFR (ρ 0.47, p = 0.23).
Table 2 Relationship between gold-standard and new methods of measuring fractional intestinal calcium absorption in cohort 1
New method FCAa Correlation coefficient (p-value) Biasb (p-value) Linear regression formula R2 Biasb (p-value) RMSPEc
1 h Serum 0.14 ± 0.06 0.57 (0.008) 0.055 (<0.001) Value x 0.5942 + 0.1119 = FCA 0.29 0 (0.999) 0.052
3 h Serum 0.20 ± 0.09 0.72 (<0.001) -0.003 (0.805) Value x 0.577 + 0.081 = FCA 0.58 0 (0.997) 0.040
5 h Serum 0.18 ± 0.07 0.65 (0.002) 0.012 (0.386) Value x 0.541 + 0.096 = FCA 0.36 0 (0.997) 0.050
a“FCA” denotes fractional calcium absorption. Data are summarized using the mean ± SD. All new methods are compared to the referent method of measuring
intestinal calcium absorption based on the dose-corrected ratio of dual stable isotopes in a 24-h urine collection, which equaled 0.20 ± 0.06 in Cohort 1 (n = 20)
bBias was assessed using the Bland-Altman method, first reported for the raw data versus the referent values (column 4) and later reported for the derived
formula versus the referent (column 7). A Bland-Altman test p-value >0.05 indicates that there is no significant difference between paired values using the
gold-standard and the new method of measuring FCA















































































1 Hour Serum Estimate of FCA
1 Hour Serum Estimate of FCA
Correlation, =0.56, p=0.011
Correlation, =0.40, p=0.286
Bland-Altman bias 0.055, p<0.001
Bland Altman bias 0.090, p=0.005
Fig. 1 One Hour Serum Isotope Estimates Compared to 24-h Urine Fractional Calcium Absorption (FCA) Values. One-hour serum estimates correlated
with 24-h urine FCA in Cohort 1 (ρ = 0.56, p = 0.011, (a), but introduced significant bias in FCA estimates (b). In Cohort 2, we found no correlation
between 1-h serum estimates of FCA and 24-h urine fractional calcium absorption (ρ = 0.40, p = 0.286, (c). Thus, testing of bias via Bland-Altman analysis
(d) was not relevant
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Additionally, we detected a statistically significant bias,
with overestimation of FCA when using the 3-h serum
measurement (+0.043, p = 0.015) or the 3-h serum meas-
urement and GFR (+0.047, p = 0.007).
Discussion
Adequate calcium intake and absorption is a critical nutri-
tional aspect of preventing or treating osteoporosis [19].
Postmenopausal women experience a 20-25 % decline in
calcium absorption between the ages of 40 and 60 attrib-
uted to increasing age and estrogen deficiency [5]. As low
calcium absorption is a risk factor for hip fracture [2], its
measurement could be useful clinically. We evaluated
whether FCA could be estimated by serum calcium tracer
levels in postmenopausal women with vitamin D insuffi-
ciency. In Cohort 1, 3-h serum isotope levels were more
accurate than 1-h or 5-h serum measurements, but only
explained 58 % of the variance in true FCA. Unfortunately,
we could not corroborate 3-h serum tracer levels as a valid
method of measuring FCA in a second cohort of women
with very similar characteristics.
Previous studies (Table 4) reported successful use of
serum measurements to estimate FCA. Depending on the
study, spot serum tracer levels explained 81 to 94 % of the
variability in calcium absorption. Regrettably, the pre-
defined “gold-standard” method for measuring FCA dif-
fered by study. Two studies [8, 9] compared spot serum
isotope values to average FCA values obtained using three
different “gold standard” methods: the oral to intravenous
isotope ratio in a serum sample at 24 h, in a 24-h urine
collection, and FCA based on kinetic modeling. A third
study [3] defined the gold standard as the average value of
tracer ratios (oral to intravenous) in multiple serum and
urine samples collected over 6-10 days following tracer
administration. A fourth study [10] used the ratio of cu-
mulative recovery of oral to intravenous isotope in three
consecutive eight hour urine collections as described by
Yergey et al. [12]. In a fifth study [20], the gold standard
method was the ratio of 5-h oral calcium specific activity
to the 3-h intravenous calcium specific activity. None of
the studies used Bland-Altman statistics to compare spot
serum tracer estimates to gold-standard measures of FCA.
There are other reasons why our study disagrees with
prior studies on whether a spot serum tracer level can ac-
curately measure FCA. We examined FCA in post-
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Correlation, =0.72, p<0.001 
Mean 
Fig. 2 Three Hour Serum Isotope Estimates Compared to 24-h Urine Fractional Calcium Absorption (FCA) Values. Three-hour serum estimates
correlated with 24-h urine FCA in Cohort 1 (ρ = 0.72, p < 0.001, (a) and values were not biased (b). However in Cohort 2, we found no correlation
between 3-h serum estimates of FCA and 24-h urine FCA (ρ = 0.03, p = 0.932, (c). Thus, testing of bias via Bland-Altman analysis (d) was not relevant
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previous studies recruited men [10, 20], adolescent or pre-
menopausal women [8, 9] or postmenopausal women
without regard to vitamin D status [3]. Several studies
(Table 4) measured FCA multiple times in one individual;
an approach that likely overestimates correlations between
serum methods and gold-standard methods of estimating
FCA. Whereas nearly all prior studies used correlation
coefficients to compare different methods of measur-
ing calcium absorption, the more rigorous Bland-
Altman test to estimate bias was not utilized. Finally,
only one study [8] validated their findings in a separ-
ate patient cohort.
Our study has several strengths. Our population of post-
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Correlation, =0.65, p=0.002 
Correlation, =0.75, p=0.020 
Bland-Altman bias 0.012, p=0.386 
Bland-Altman bias 0.024, p=0.255 
Fig. 3 Five Hour Serum Isotope Estimates Compared to 24-h Urine Fractional Calcium Absorption (FCA) Values. Five-hour serum FCA estimates
correlated with 24-h urine FCA in Cohort 1 (ρ = 0.65, p = 0.002, (a) and values were not biased (b). In Cohort 2, 5-h serum estimates of FCA
correlated with 24-h urine fractional calcium absorption (ρ = 0.75, p = 0.020, c). Bias is illustrated in (d); the solid line represents the mean
degree of bias and dashed lines indicate the 95 % limits of agreement. Bias was not statistically significant in Cohort 2, but 5-h serum
estimates explained only 35 % of the variance in Cohort 2 24-h urine FCA values
Table 3 Assessment of Alternative Methods to Estimate Fractional Calcium Absorption in Cohort 2
New
Methoda








Biasc, e (p-value) RMSPEa, d, e
3-h
Serum
0.21 ± 0.04 0.009 (0.767) Value x 0.577 +
0.081 = FCA




0.21 ± 0.05 N/A Value x 0.585 +
0.001 x GFR +
0.031 = FCA
0.02 (0.966) 0.071 0.45 (0.260) 0.047 (0.007) 0.037
aThe two best methods identified in Cohort 1 were validated in Cohort 2
b“FCA” denotes intestinal fractional calcium absorption. Data are summarized using the mean ± SD. All new methods are compared to referent method of
measuring intestinal calcium absorption based on the dose-corrected ratio of dual stable isotopes in a 24-h urine collection, which equaled 0.23 ± 0.07 in Cohort
2 (n = 9)
cBias was assessed using the Bland-Altman method, first reported for the raw data versus the referent values (column 3) and then reported for the derived
formula minus one outlier (column 8). A Bland-Altman test p-value >0.05 indicates that there is no significant difference between paired values using the
gold-standard and the new method of measuring FCA
d“RMSPE” indicates the root mean square prediction error
eData without one outlier who had low FCA (12 %)
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most likely to benefit from accurate measurement of FCA.
We used the gold-standard approach to measure FCA and
collected urine for 24 h during an inpatient hospital stay.
We used the Bland-Altman test to assess potential bias
between measurement methods, in addition to using cor-
relation coefficients. We matched subjects’ inpatient meals
to their usual outpatient nutritional intake. We assessed
new measurement methods in a second cohort of women.
Of course, our study has some weaknesses. We cannot
state whether our results would apply to other groups of
patients. While our study sample size was small, it is
nearly identical to that of several other studies (Table 4).
Given the poor correlation coefficients and significant bias
using serum measurements, it seems very unlikely that
our conclusions would be altered by studying more
subjects.
Conclusion
We conclude that serum tracer levels correlate with
gold-standard FCA values, but cannot replace gold-
standard FCA measurements. Additionally, even in the
first cohort of women, the best spot serum isotope
method only explained 58 % of the variance in FCA. We
recommend continued use of dual calcium tracers and a
subsequent 24-h urine collection for accurate measure-
ment of FCA.
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Table 4 Summary of studies comparing tracer methods to estimate fractional calcium absorptiona
Subjects Measures, New Method, Gold Standard Method (GSM) Linear Regression Model to Estimate FCAb Variance,
p-value
265 women 554 measures, 5-h serum, GSM: average of oral to iv tracer values
in multiple serum and urine samples collected for 6-10 days
cFCA = 2.3045(Serum) + 0.021953(Weight0.425)
(Height0.725) - 0.1735
R2 0.91
≥35 years old [3] p not
provided
30 men New method at baseline and GSM 6 days later, 5-h serum,
GSM: quotient of 5-h oral radioactivity to 3-h iv radioactivity
cFCA = (Serum)0.92373 x (0.385 x (Height0.5285)
(Weight0.3721))
R2 0.90
20-60 years old [20] p < 0.001
12 men 24 measures, 5-h serum, GSM: average of oral to iv tracer values
in multiple serum and urine samples collected at multiple times,
and quotient of 5-h oral radioactivity to 3-h iv radioactivity
Not provided R2 0.92




19 measures, 4-h serum, GSM: ratio of cumulative recovery
of oral to iv tracers in 24-h urine collection
eFCA = ratio of oral calcium tracer to
intravenous tracer
R2 0.83
≥50 years old [10] p < 0.001
22 girls 31 measures, 4-h serum, GSM: Average of 3 values- oral to iv
ratio in 24-h serum, 24-h urine and kinetic model
c,d,fFCA = 1.334(Serum)0.7872BSA1.7132e(-0.01652PMA) R2 0.94
10-15 years old [8] p < 0.001
26 women 129 measures, 4, 5, 6 h serum, GSM: Average of 3 values- oral
to iv ratio in 24-h serum, 24-h urine and kinetic model
cFCA = 1.3609(4 h Serum)0.8703BSA0.8708 R2 0.78
19-67 years old [9] p < 0.001
cFCA = 1.4065(5 h Serum)0.8437BSA0.7785 R2 0.78
p < 0.001
cFCA = 1.5828(6 h Serum)0.8636BSA0.7142 R2 0.81
p < 0.001
aStudies summarized in this table reported the amount of variance (R2) in fractional calcium absorption explained by a spot serum tracer level. Two other notable
studies [12, 17] reported correlation coefficients only
b“FCA” denotes fractional calcium absorption
cIn this formula, the serum level reflects the radioactivity or stable calcium isotope level as a fractional dose per mL, per gram/mL of serum calcium
d“BSA” refers to body surface area as defined by the DuBois equation [22]
eIn this study, the oral tracer was given with breakfast and the intravenous tracer was given two hours later, with serum drawn 4 h after breakfast
f“PMA” refers to post-menarchal age
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